Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight Life Science Investing
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates Medical Device Investing
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ Pharmaceutical Investing
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights Life Science Investing
Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates Life Science Investing
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress Life Science Investing
Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights Biotech Investing
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys Artificial Intelligence Investing
Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting Life Science Investing
